Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.

referredUnited States· United States Congress· EN

Introduced

18 March 2019

Last action

—

Status

Referred to the Subcommittee on Health.

Summary

This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

Introduced in House (text)

View file Download file

Introduced in House (text)
Introduced in House · EN · 18 March 2019
View Download Open at official source
Introduced in House (PDF)
Introduced in House · EN · 18 March 2019
View Download Open at official source
Introduced in House
summary · EN · 18 March 2019
Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/116th-congress/house-resolution/242
Open data entity: https://api.congress.gov/v3/bill/116/hres/242